Third Harmonic Bio plans to liquidate the company, sell urticaria treatment
Source: SeekingAlpha
2025-04-14 11:09:34 ET
More on Third Harmonic Bio
- Seeking Alpha’s Quant Rating on Third Harmonic Bio
- Historical earnings data for Third Harmonic Bio
- Financial information for Third Harmonic Bio
Read the full article on Seeking Alpha
For further details see:
Third Harmonic Bio plans to liquidate the company, sell urticaria treatment
Third Harmonic Bio Inc.
NASDAQ: THRD
THRD Trading
-0.56% G/L:
$5.38 Last:
1,417,958 Volume:
$5.41 Open:
THRD Latest News
THRD Stock Data
$242,787,548
21,345,447
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
